S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

EYPT EyePoint Pharmaceuticals Inc

5.67

0.12 (2.16%)

Apr 17 2025 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Mar 2025 to Apr 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Apr 2024 to Apr 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals Inc News

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Wednesday 16 April 2025 (2 days ago) • GlobeNewswire Inc.

EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
Thursday 27 March 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 March 2025 (4 weeks ago) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Monday 17 March 2025 (1 month ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 6 March 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 5 March 2025 (1 month ago) • Edgar (US Regulatory)

EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments
Wednesday 5 March 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 4 March 2025 (1 month ago) • Edgar (US Regulatory)

EyePoint Announces Participation at Upcoming Investor Conferences
Tuesday 4 March 2025 (1 month ago) • GlobeNewswire Inc.

EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
Wednesday 26 February 2025 (2 months ago) • GlobeNewswire Inc.

EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
Tuesday 25 February 2025 (2 months ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Monday 17 February 2025 (2 months ago) • GlobeNewswire Inc.

More EyePoint Pharmaceuticals Inc News Articles

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions